[HTML] nature.com

[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow, B Merrick… - Nature …, 2021 - nature.com
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …
被引用次数：99 相关文章

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - search.proquest.com
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …
[HTML] nih.gov

[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - ncbi.nlm.nih.gov
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow, B Merrick… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> COVID-19 vaccine design and vaccination
rollout need to take into account a detailed understanding of antibody durability and cross …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - research.ed.ac.uk
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.

L Dupont, LB Snell, C Graham, J Seow, B Merrick… - 2021 - cabidigitallibrary.org
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - europepmc.org
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.

L Dupont, LB Snell, C Graham, J Seow… - Nature …, 2021 - europepmc.org
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …